SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.
Date of Report (Date of Earliest Event Reported): December 1, 2000
----------------
VITRO DIAGNOSTICS, INC.
------------------------------------------------------
(Exact name of registrant as specified in its charter)
Nevada 0-17378 84-1012042
---------------- ------------ -------------------
(State or other (Commission (I.R.S. Employer
jurisdiction of File Number) Identification No.)
incorporation)
8100 Southpark Way, B-1
Littleton, Colorado 80120
---------------------------------------- -------------
(Address of Principal Executive Offices) (Zip Code)
Registrant's telephone number including area code: (303) 794-2000
--------------
-------------------------------------------------------------
(Former name or former address, if changed since last report)
<PAGE>
Item 9. Regulation FD Disclosure 7
On December 1, 2000, Vitro Diagnostics, Inc. held its annual meeting of the
shareholders. A copy of the presentation materials of the Company's President
and Chief Executive Officer that were used at that meeting and which might be
used from time to time thereafter is filed as exhibit 99.1, attached hereto.
2
